
An Urgent Advocacy Update on Lung Allocation Changes
Our advocacy efforts are continuing, and we are committed to keeping you informed! In November of 2025, the OPTN Board …
The Lung Transplant Foundation is officially joining forces with The International Society for Heart & Lung Transplantation (ISHLT) to amplify advocacy efforts regarding the recent change to how donor lungs are distributed.

The policy change, which took effect in May, reallocated critical points away from categories that impact waitlist survival, moving them to a new category called “Placement Efficiency”. This change occurred despite unanimous opposition from the medical experts on the OPTN Lung Transplantation Committee. It also bypassed the standard prospective public comment period normally required for major policy changes.
In a newly released response, the ISHLT leveled heavy criticism at both the lack of evidence supporting the change, and the use of the emergency action pathway itself. The Society highlighted concerns that the new framework creates a higher dependence on donor-recipient geographic proximity, which could worsen geographic disparities and severely restrict access to transplantation for biologically disadvantaged groups, including blood type O candidates and highly sensitized patients.
“Major allocation policy changes should be supported by rigorous evidence demonstrating both the existence of a problem and the effectiveness of the proposed remedy,” the ISHLT noted in their statement, concluding that the OPTN standard had not been met.
The Lung Transplant Foundation, alongside the ISHLT and a coalition of 17 other pulmonary patient advocacy organizations, is making a final push to rally the patient and caregiver community before the public comment window closes on July 3rd.
To date, nearly 350 advocates have utilized our streamlined advocacy platform to submit a public comment to the OPTN Board of Directors. Our goal is to exceed 500 public submissions to encourage a reassessment of the new policy, allow for the completion of omitted clinical modeling, and firmly protect patient equity.
Every voice matters. You can access the full ISHLT public comment letter directly via the ISHLT Response to Update on Lung Continuous Distribution Policy. To voice your opposition using our one-minute automated letter template, please visit our official action portal below.

Our advocacy efforts are continuing, and we are committed to keeping you informed! In November of 2025, the OPTN Board …

The Lung Transplant Foundation has submitted a formal letter to the Organ Procurement and Transplantation Network (OPTN) requesting greater clarity …

How the November 2025 Lung Allocation Policy Change Happened—and Why Patients Were Left Out A recent decision about how lungs …
Disclaimer: This website does not provide medical advice. The information, including but not limited to text, graphics, images, and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment before undertaking any new health care regimen. Never disregard any professional medical advice or delay in seeking care because of something you have read on this website.